About rxsight inc - RXST
RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. It also commercializes adjustable intraocular lens (IOL) that is customized after cataract surgery. The company was founded on March 5, 1997 and is headquartered in Aliso Viejo, CA.
RXST At a Glance
RxSight, Inc.
100 Columbia
Aliso Viejo, California 92656
| Phone | 1-949-521-7830 | Revenue | 139.93M | |
| Industry | Electronic Components | Net Income | -27,455,000.00 | |
| Sector | Electronic Technology | 2024 Sales Growth | 57.085% | |
| Fiscal Year-end | 12 / 2025 | Employees | 498 | |
| View SEC Filings |
RXST Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 9.55 |
| Price to Book Ratio | 4.942 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -33.44 |
| Enterprise Value to Sales | 7.942 |
| Total Debt to Enterprise Value | 0.011 |
RXST Efficiency
| Revenue/Employee | 280,977.912 |
| Income Per Employee | -55,130.522 |
| Receivables Turnover | 4.656 |
| Total Asset Turnover | 0.555 |
RXST Liquidity
| Current Ratio | 11.355 |
| Quick Ratio | 10.504 |
| Cash Ratio | 9.168 |
RXST Profitability
| Gross Margin | 70.71 |
| Operating Margin | -26.341 |
| Pretax Margin | -19.585 |
| Net Margin | -19.621 |
| Return on Assets | -10.895 |
| Return on Equity | -12.434 |
| Return on Total Capital | -9.353 |
| Return on Invested Capital | -12.091 |
RXST Capital Structure
| Total Debt to Total Equity | 4.372 |
| Total Debt to Total Capital | 4.189 |
| Total Debt to Total Assets | 3.826 |
| Long-Term Debt to Equity | 4.026 |
| Long-Term Debt to Total Capital | 3.857 |